Evolution Advisers’s Merck MRK Stock Holding History

Evolution Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5	Closed	–	–	569
2026 Q2	$0	Buy	+5	New	+$585	﹤0.01%	625
2025 Q2	–	Sell	-50	Closed	-$4K	–	154
2025 Q1	$4K	Buy	+50	New	+$4.67K	﹤0.01%	140

Other funds holding MRK

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Evolution Advisers's MRK Position: Q3 2026 in Review

Evolution Advisers sold out of Merck (MRK) in Q3 2026, closing a stake of 5 shares.

Evolution Advisers first reported a position in MRK in Q1 2025 and held it in 2 quarters. The position peaked at $4K in Q1 2025. 2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

Evolution Advisers reported no remaining Merck position as of Q3 2026 after selling out during the quarter.
Evolution Advisers sold 5 Merck shares in Q3 2026.
Evolution Advisers first reported a position in Merck in Q1 2025 and held it in 2 quarters.
Evolution Advisers's Merck position peaked at $4K in Q1 2025.
2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.